Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Jonasch

Showing results (1-10 of 271) with videos related to

Pageof 28
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2019
NCCN Guidelines Updates: Management of Metastatic Kidney CancerEric Jonasch
Journal of the National Comprehensive Cancer Network : JNCCN|May 22, 2015
Kidney cancer: current and novel treatment optionsEric Jonasch
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2018
Updates to the Management of Kidney CancerEric Jonasch
Journal of the National Comprehensive Cancer Network : JNCCN|May 19, 2017
Incorporating New Systemic Therapies in Kidney Cancer TreatmentEric Jonasch
Current Oncology Reports|April 29, 2010
Prognostic and predictive factors in the targeted therapy era: filling in the blanksEric Jonasch
Expert Review of Anticancer Therapy|December 26, 2006
Presurgical therapy in metastatic renal cell carcinomaEric Jonasch
Cancer|March 17, 2009
Prognostic models: from the fates to the futureEric Jonasch
Cancers|November 11, 2022
Systemic Therapy Development in Von Hippel-Lindau Disease: An Outsized Contribution from an Orphan DiseaseVivek Narayan, Eric Jonasch
Hematology/Oncology Clinics of North America|June 3, 2023
Management of Brain Metastases in Metastatic Renal Cell CarcinomaElshad Hasanov, Eric Jonasch
Expert Opinion on Investigational Drugs|May 4, 2021
MK-6482 as a potential treatment for von Hippel-Lindau disease-associated clear cell renal cell carcinomaElshad Hasanov, Eric Jonasch
Pageof 28

Showing results (1-10 of 271) with videos related to

Sort By:
Pageof 28
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2019
NCCN Guidelines Updates: Management of Metastatic Kidney CancerEric Jonasch
Journal of the National Comprehensive Cancer Network : JNCCN|May 22, 2015
Kidney cancer: current and novel treatment optionsEric Jonasch
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2018
Updates to the Management of Kidney CancerEric Jonasch
Journal of the National Comprehensive Cancer Network : JNCCN|May 19, 2017
Incorporating New Systemic Therapies in Kidney Cancer TreatmentEric Jonasch
Current Oncology Reports|April 29, 2010
Prognostic and predictive factors in the targeted therapy era: filling in the blanksEric Jonasch
Expert Review of Anticancer Therapy|December 26, 2006
Presurgical therapy in metastatic renal cell carcinomaEric Jonasch
Cancer|March 17, 2009
Prognostic models: from the fates to the futureEric Jonasch
Cancers|November 11, 2022
Systemic Therapy Development in Von Hippel-Lindau Disease: An Outsized Contribution from an Orphan DiseaseVivek Narayan, Eric Jonasch
Hematology/Oncology Clinics of North America|June 3, 2023
Management of Brain Metastases in Metastatic Renal Cell CarcinomaElshad Hasanov, Eric Jonasch
Expert Opinion on Investigational Drugs|May 4, 2021
MK-6482 as a potential treatment for von Hippel-Lindau disease-associated clear cell renal cell carcinomaElshad Hasanov, Eric Jonasch
Pageof 28